← Back to Search

Activity-based Companion Care for Dementia (MEMORI Corps Trial)

N/A

Recruiting

Led By Quincy Samus, PhD

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have an established physician clinical diagnosis of dementia (any stage) and confirmed with the Clinical Dementia Rating Scale of >0.5

PWD must be able to participate in >2 basic Activities of Daily Living

Must not have

PWD planned transition from home in less than 6 months

PWD at end-stage disease (e.g. bed-bound, non-communicative, or hospice)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 12 weeks

Awards & highlights

Summary

This trial is testing whether a 12-week program delivered by older volunteers can help people with dementia and their caregivers. The volunteers will either serve in the program immediately (active duty) or after a 12-week waitlist period (control group).

Who is the study for?

This trial is for English-speaking pairs of people with dementia (PWD) and their informal caregivers (CG) living in Baltimore City or County. PWD should be diagnosed with dementia, able to do some daily activities, and not have had formal respite care recently. Caregivers must live with the PWD and assist them. Volunteers aged 55+ who pass health checks can also join.

What is being tested?

The MEMORI Corps program matches trained senior volunteers with dementia patients and caregivers for a 12-week period to provide activity-based companion care. The study compares this intervention against an augmented waitlist control group to assess its effectiveness.

What are the potential side effects?

Since this trial involves non-medical interventions like companionship and activities, there are no direct medical side effects expected from participation in the MEMORI Corps program.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with dementia, confirmed by a specific test score above 0.5.

Select...

I can perform more than two basic daily activities on my own.

Select...

I am over 18 and considered a dependable caregiver.

Select...

I live with and help someone with daily activities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I plan to move out of my home within 6 months.

Select...

I am at the end stage of my disease and cannot move or communicate effectively.

Select...

I have trouble controlling my bladder or bowels.

Select...

I have severe behavioral issues that could harm me or others.

Select...

I am unable to understand or sign the consent form.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Gait speed

Change in activity engagement as assessed by the Community Healthy Activities Model Program for Seniors activity questionnaire

Change in depressive symptoms in caregivers as assessed by The Patient Health Questionnaire (PHQ) - 9

+5 more

Secondary study objectives

Change in depressive symptoms in senior companion volunteers as assessed by The Patient Health Questionnaire (PHQ) - 9

Change in home and community-based long term services and supports use health services use as assessed by the Resource Utilization in Dementia/Services Utilization and Resources Survey

Change in objective caregiver burden as assessed by time estimates in performing tasks

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: ControlExperimental Treatment1 Intervention

Augmented waitlist control.

Group II: Active InterventionExperimental Treatment1 Intervention

Intervention arm with MEMORI Corps program

0 / 9Eligibility criteria met

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,307 Previous Clinical Trials

14,861,349 Total Patients Enrolled

31 Trials studying Dementia

81,674 Patients Enrolled for Dementia

Alzheimer's AssociationOTHER

95 Previous Clinical Trials

41,740 Total Patients Enrolled

33 Trials studying Dementia

32,001 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,733 Previous Clinical Trials

28,054,443 Total Patients Enrolled

281 Trials studying Dementia

23,628,461 Patients Enrolled for Dementia

Media Library

MEMORI Corps program Clinical Trial Eligibility Overview. Trial Name: NCT03896711 — N/A

Dementia Research Study Groups: Active Intervention, Control

Dementia Clinical Trial 2023: MEMORI Corps program Highlights & Side Effects. Trial Name: NCT03896711 — N/A

MEMORI Corps program 2023 Treatment Timeline for Medical Study. Trial Name: NCT03896711 — N/A

~0 spots leftby Sep 2024

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.